Table of Content

1 Study Coverage
1.1 Autologous Cell Therapy Products Product Introduction
1.2 Market by Type
1.2.1 Global Autologous Cell Therapy Products Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Autologous Stem Cell Transplants
1.2.3 Autologous T Cell Therapies
1.2.4 Platelet-Rich Plasma (PRP) Therapy
1.2.5 Others
1.3 Market by Application
1.3.1 Global Autologous Cell Therapy Products Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Cancer
1.3.3 Hemophilia
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Autologous Cell Therapy Products Sales Estimates and Forecasts 2018-2029
2.2 Global Autologous Cell Therapy Products Revenue by Region
2.2.1 Global Autologous Cell Therapy Products Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Autologous Cell Therapy Products Revenue by Region (2018-2024)
2.2.3 Global Autologous Cell Therapy Products Revenue by Region (2024-2029)
2.2.4 Global Autologous Cell Therapy Products Revenue Market Share by Region (2018-2029)
2.3 Global Autologous Cell Therapy Products Sales Estimates and Forecasts 2018-2029
2.4 Global Autologous Cell Therapy Products Sales by Region
2.4.1 Global Autologous Cell Therapy Products Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Autologous Cell Therapy Products Sales by Region (2018-2024)
2.4.3 Global Autologous Cell Therapy Products Sales by Region (2024-2029)
2.4.4 Global Autologous Cell Therapy Products Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Autologous Cell Therapy Products Sales by Manufacturers
3.1.1 Global Autologous Cell Therapy Products Sales by Manufacturers (2018-2024)
3.1.2 Global Autologous Cell Therapy Products Sales Market Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Autologous Cell Therapy Products in 2022
3.2 Global Autologous Cell Therapy Products Revenue by Manufacturers
3.2.1 Global Autologous Cell Therapy Products Revenue by Manufacturers (2018-2024)
3.2.2 Global Autologous Cell Therapy Products Revenue Market Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by Autologous Cell Therapy Products Revenue in 2022
3.3 Global Key Players of Autologous Cell Therapy Products, Industry Ranking, 2021 VS 2022 VS 2024
3.4 Global Autologous Cell Therapy Products Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Autologous Cell Therapy Products Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Autologous Cell Therapy Products, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Autologous Cell Therapy Products, Product Offered and Application
3.8 Global Key Manufacturers of Autologous Cell Therapy Products, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Autologous Cell Therapy Products Sales by Type
4.1.1 Global Autologous Cell Therapy Products Historical Sales by Type (2018-2024)
4.1.2 Global Autologous Cell Therapy Products Forecasted Sales by Type (2024-2029)
4.1.3 Global Autologous Cell Therapy Products Sales Market Share by Type (2018-2029)
4.2 Global Autologous Cell Therapy Products Revenue by Type
4.2.1 Global Autologous Cell Therapy Products Historical Revenue by Type (2018-2024)
4.2.2 Global Autologous Cell Therapy Products Forecasted Revenue by Type (2024-2029)
4.2.3 Global Autologous Cell Therapy Products Revenue Market Share by Type (2018-2029)
4.3 Global Autologous Cell Therapy Products Price by Type
4.3.1 Global Autologous Cell Therapy Products Price by Type (2018-2024)
4.3.2 Global Autologous Cell Therapy Products Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global Autologous Cell Therapy Products Sales by Application
5.1.1 Global Autologous Cell Therapy Products Historical Sales by Application (2018-2024)
5.1.2 Global Autologous Cell Therapy Products Forecasted Sales by Application (2024-2029)
5.1.3 Global Autologous Cell Therapy Products Sales Market Share by Application (2018-2029)
5.2 Global Autologous Cell Therapy Products Revenue by Application
5.2.1 Global Autologous Cell Therapy Products Historical Revenue by Application (2018-2024)
5.2.2 Global Autologous Cell Therapy Products Forecasted Revenue by Application (2024-2029)
5.2.3 Global Autologous Cell Therapy Products Revenue Market Share by Application (2018-2029)
5.3 Global Autologous Cell Therapy Products Price by Application
5.3.1 Global Autologous Cell Therapy Products Price by Application (2018-2024)
5.3.2 Global Autologous Cell Therapy Products Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada Autologous Cell Therapy Products Market Size by Type
6.1.1 US & Canada Autologous Cell Therapy Products Sales by Type (2018-2029)
6.1.2 US & Canada Autologous Cell Therapy Products Revenue by Type (2018-2029)
6.2 US & Canada Autologous Cell Therapy Products Market Size by Application
6.2.1 US & Canada Autologous Cell Therapy Products Sales by Application (2018-2029)
6.2.2 US & Canada Autologous Cell Therapy Products Revenue by Application (2018-2029)
6.3 US & Canada Autologous Cell Therapy Products Market Size by Country
6.3.1 US & Canada Autologous Cell Therapy Products Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Autologous Cell Therapy Products Sales by Country (2018-2029)
6.3.3 US & Canada Autologous Cell Therapy Products Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Autologous Cell Therapy Products Market Size by Type
7.1.1 Europe Autologous Cell Therapy Products Sales by Type (2018-2029)
7.1.2 Europe Autologous Cell Therapy Products Revenue by Type (2018-2029)
7.2 Europe Autologous Cell Therapy Products Market Size by Application
7.2.1 Europe Autologous Cell Therapy Products Sales by Application (2018-2029)
7.2.2 Europe Autologous Cell Therapy Products Revenue by Application (2018-2029)
7.3 Europe Autologous Cell Therapy Products Market Size by Country
7.3.1 Europe Autologous Cell Therapy Products Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Autologous Cell Therapy Products Sales by Country (2018-2029)
7.3.3 Europe Autologous Cell Therapy Products Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Autologous Cell Therapy Products Market Size
8.1.1 China Autologous Cell Therapy Products Sales (2018-2029)
8.1.2 China Autologous Cell Therapy Products Revenue (2018-2029)
8.2 China Autologous Cell Therapy Products Market Size by Application
8.2.1 China Autologous Cell Therapy Products Sales by Application (2018-2029)
8.2.2 China Autologous Cell Therapy Products Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Autologous Cell Therapy Products Market Size by Type
9.1.1 Asia Autologous Cell Therapy Products Sales by Type (2018-2029)
9.1.2 Asia Autologous Cell Therapy Products Revenue by Type (2018-2029)
9.2 Asia Autologous Cell Therapy Products Market Size by Application
9.2.1 Asia Autologous Cell Therapy Products Sales by Application (2018-2029)
9.2.2 Asia Autologous Cell Therapy Products Revenue by Application (2018-2029)
9.3 Asia Autologous Cell Therapy Products Sales by Region
9.3.1 Asia Autologous Cell Therapy Products Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Autologous Cell Therapy Products Revenue by Region (2018-2029)
9.3.3 Asia Autologous Cell Therapy Products Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Autologous Cell Therapy Products Market Size by Type
10.1.1 Middle East, Africa and Latin America Autologous Cell Therapy Products Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Autologous Cell Therapy Products Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Autologous Cell Therapy Products Market Size by Application
10.2.1 Middle East, Africa and Latin America Autologous Cell Therapy Products Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Autologous Cell Therapy Products Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Autologous Cell Therapy Products Sales by Country
10.3.1 Middle East, Africa and Latin America Autologous Cell Therapy Products Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Autologous Cell Therapy Products Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Autologous Cell Therapy Products Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Novartis
11.1.1 Novartis Company Information
11.1.2 Novartis Overview
11.1.3 Novartis Autologous Cell Therapy Products Sales, Price, Revenue and Gross Margin (2018-2024)
11.1.4 Novartis Autologous Cell Therapy Products Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Novartis Recent Developments
11.2 Gilead Sciences
11.2.1 Gilead Sciences Company Information
11.2.2 Gilead Sciences Overview
11.2.3 Gilead Sciences Autologous Cell Therapy Products Sales, Price, Revenue and Gross Margin (2018-2024)
11.2.4 Gilead Sciences Autologous Cell Therapy Products Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Gilead Sciences Recent Developments
11.3 Bristol-Myers Squibb
11.3.1 Bristol-Myers Squibb Company Information
11.3.2 Bristol-Myers Squibb Overview
11.3.3 Bristol-Myers Squibb Autologous Cell Therapy Products Sales, Price, Revenue and Gross Margin (2018-2024)
11.3.4 Bristol-Myers Squibb Autologous Cell Therapy Products Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Bristol-Myers Squibb Recent Developments
11.4 Johnson & Johnson
11.4.1 Johnson & Johnson Company Information
11.4.2 Johnson & Johnson Overview
11.4.3 Johnson & Johnson Autologous Cell Therapy Products Sales, Price, Revenue and Gross Margin (2018-2024)
11.4.4 Johnson & Johnson Autologous Cell Therapy Products Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Johnson & Johnson Recent Developments
11.5 Autolus Therapeutics
11.5.1 Autolus Therapeutics Company Information
11.5.2 Autolus Therapeutics Overview
11.5.3 Autolus Therapeutics Autologous Cell Therapy Products Sales, Price, Revenue and Gross Margin (2018-2024)
11.5.4 Autolus Therapeutics Autologous Cell Therapy Products Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Autolus Therapeutics Recent Developments
11.6 FOSUNKite
11.6.1 FOSUNKite Company Information
11.6.2 FOSUNKite Overview
11.6.3 FOSUNKite Autologous Cell Therapy Products Sales, Price, Revenue and Gross Margin (2018-2024)
11.6.4 FOSUNKite Autologous Cell Therapy Products Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 FOSUNKite Recent Developments
11.7 JW Therapeutics
11.7.1 JW Therapeutics Company Information
11.7.2 JW Therapeutics Overview
11.7.3 JW Therapeutics Autologous Cell Therapy Products Sales, Price, Revenue and Gross Margin (2018-2024)
11.7.4 JW Therapeutics Autologous Cell Therapy Products Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 JW Therapeutics Recent Developments
11.8 CARsgen Therapeutics
11.8.1 CARsgen Therapeutics Company Information
11.8.2 CARsgen Therapeutics Overview
11.8.3 CARsgen Therapeutics Autologous Cell Therapy Products Sales, Price, Revenue and Gross Margin (2018-2024)
11.8.4 CARsgen Therapeutics Autologous Cell Therapy Products Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 CARsgen Therapeutics Recent Developments
11.9 Sorrento Therapeutics
11.9.1 Sorrento Therapeutics Company Information
11.9.2 Sorrento Therapeutics Overview
11.9.3 Sorrento Therapeutics Autologous Cell Therapy Products Sales, Price, Revenue and Gross Margin (2018-2024)
11.9.4 Sorrento Therapeutics Autologous Cell Therapy Products Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Sorrento Therapeutics Recent Developments
11.10 Mustang Bio
11.10.1 Mustang Bio Company Information
11.10.2 Mustang Bio Overview
11.10.3 Mustang Bio Autologous Cell Therapy Products Sales, Price, Revenue and Gross Margin (2018-2024)
11.10.4 Mustang Bio Autologous Cell Therapy Products Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Mustang Bio Recent Developments
11.11 Cellectis
11.11.1 Cellectis Company Information
11.11.2 Cellectis Overview
11.11.3 Cellectis Autologous Cell Therapy Products Sales, Price, Revenue and Gross Margin (2018-2024)
11.11.4 Cellectis Autologous Cell Therapy Products Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Cellectis Recent Developments
11.12 Allogene Therapeutics
11.12.1 Allogene Therapeutics Company Information
11.12.2 Allogene Therapeutics Overview
11.12.3 Allogene Therapeutics Autologous Cell Therapy Products Sales, Price, Revenue and Gross Margin (2018-2024)
11.12.4 Allogene Therapeutics Autologous Cell Therapy Products Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Allogene Therapeutics Recent Developments
11.13 Celyad Oncology
11.13.1 Celyad Oncology Company Information
11.13.2 Celyad Oncology Overview
11.13.3 Celyad Oncology Autologous Cell Therapy Products Sales, Price, Revenue and Gross Margin (2018-2024)
11.13.4 Celyad Oncology Autologous Cell Therapy Products Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Celyad Oncology Recent Developments
11.14 Bluebird Bio
11.14.1 Bluebird Bio Company Information
11.14.2 Bluebird Bio Overview
11.14.3 Bluebird Bio Autologous Cell Therapy Products Sales, Price, Revenue and Gross Margin (2018-2024)
11.14.4 Bluebird Bio Autologous Cell Therapy Products Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Bluebird Bio Recent Developments
11.15 Lonza
11.15.1 Lonza Company Information
11.15.2 Lonza Overview
11.15.3 Lonza Autologous Cell Therapy Products Sales, Price, Revenue and Gross Margin (2018-2024)
11.15.4 Lonza Autologous Cell Therapy Products Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 Lonza Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Autologous Cell Therapy Products Industry Chain Analysis
12.2 Autologous Cell Therapy Products Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Autologous Cell Therapy Products Production Mode & Process
12.4 Autologous Cell Therapy Products Sales and Marketing
12.4.1 Autologous Cell Therapy Products Sales Channels
12.4.2 Autologous Cell Therapy Products Distributors
12.5 Autologous Cell Therapy Products Customers
13 Market Dynamics
13.1 Autologous Cell Therapy Products Industry Trends
13.2 Autologous Cell Therapy Products Market Drivers
13.3 Autologous Cell Therapy Products Market Challenges
13.4 Autologous Cell Therapy Products Market Restraints
14 Key Findings in The Global Autologous Cell Therapy Products Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Autologous Cell Therapy Products Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Major Manufacturers of Autologous Stem Cell Transplants
Table 3. Major Manufacturers of Autologous T Cell Therapies
Table 4. Major Manufacturers of Platelet-Rich Plasma (PRP) Therapy
Table 5. Major Manufacturers of Others
Table 6. Global Autologous Cell Therapy Products Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 7. Global Autologous Cell Therapy Products Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 8. Global Autologous Cell Therapy Products Revenue by Region (2018-2024) & (US$ Million)
Table 9. Global Autologous Cell Therapy Products Revenue by Region (2024-2029) & (US$ Million)
Table 10. Global Autologous Cell Therapy Products Revenue Market Share by Region (2018-2024)
Table 11. Global Autologous Cell Therapy Products Revenue Market Share by Region (2024-2029)
Table 12. Global Autologous Cell Therapy Products Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 13. Global Autologous Cell Therapy Products Sales by Region (2018-2024) & (K Units)
Table 14. Global Autologous Cell Therapy Products Sales by Region (2024-2029) & (K Units)
Table 15. Global Autologous Cell Therapy Products Sales Market Share by Region (2018-2024)
Table 16. Global Autologous Cell Therapy Products Sales Market Share by Region (2024-2029)
Table 17. Global Autologous Cell Therapy Products Sales by Manufacturers (2018-2024) & (K Units)
Table 18. Global Autologous Cell Therapy Products Sales Share by Manufacturers (2018-2024)
Table 19. Global Autologous Cell Therapy Products Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 20. Global Autologous Cell Therapy Products Revenue Share by Manufacturers (2018-2024)
Table 21. Global Key Players of Autologous Cell Therapy Products, Industry Ranking, 2021 VS 2022 VS 2024
Table 22. Autologous Cell Therapy Products Price by Manufacturers 2018-2024 (US$/Unit)
Table 23. Global Autologous Cell Therapy Products Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 24. Global Autologous Cell Therapy Products by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Autologous Cell Therapy Products as of 2022)
Table 25. Global Key Manufacturers of Autologous Cell Therapy Products, Manufacturing Base Distribution and Headquarters
Table 26. Global Key Manufacturers of Autologous Cell Therapy Products, Product Offered and Application
Table 27. Global Key Manufacturers of Autologous Cell Therapy Products, Date of Enter into This Industry
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Autologous Cell Therapy Products Sales by Type (2018-2024) & (K Units)
Table 30. Global Autologous Cell Therapy Products Sales by Type (2024-2029) & (K Units)
Table 31. Global Autologous Cell Therapy Products Sales Share by Type (2018-2024)
Table 32. Global Autologous Cell Therapy Products Sales Share by Type (2024-2029)
Table 33. Global Autologous Cell Therapy Products Revenue by Type (2018-2024) & (US$ Million)
Table 34. Global Autologous Cell Therapy Products Revenue by Type (2024-2029) & (US$ Million)
Table 35. Global Autologous Cell Therapy Products Revenue Share by Type (2018-2024)
Table 36. Global Autologous Cell Therapy Products Revenue Share by Type (2024-2029)
Table 37. Autologous Cell Therapy Products Price by Type (2018-2024) & (US$/Unit)
Table 38. Global Autologous Cell Therapy Products Price Forecast by Type (2024-2029) & (US$/Unit)
Table 39. Global Autologous Cell Therapy Products Sales by Application (2018-2024) & (K Units)
Table 40. Global Autologous Cell Therapy Products Sales by Application (2024-2029) & (K Units)
Table 41. Global Autologous Cell Therapy Products Sales Share by Application (2018-2024)
Table 42. Global Autologous Cell Therapy Products Sales Share by Application (2024-2029)
Table 43. Global Autologous Cell Therapy Products Revenue by Application (2018-2024) & (US$ Million)
Table 44. Global Autologous Cell Therapy Products Revenue by Application (2024-2029) & (US$ Million)
Table 45. Global Autologous Cell Therapy Products Revenue Share by Application (2018-2024)
Table 46. Global Autologous Cell Therapy Products Revenue Share by Application (2024-2029)
Table 47. Autologous Cell Therapy Products Price by Application (2018-2024) & (US$/Unit)
Table 48. Global Autologous Cell Therapy Products Price Forecast by Application (2024-2029) & (US$/Unit)
Table 49. US & Canada Autologous Cell Therapy Products Sales by Type (2018-2024) & (K Units)
Table 50. US & Canada Autologous Cell Therapy Products Sales by Type (2024-2029) & (K Units)
Table 51. US & Canada Autologous Cell Therapy Products Revenue by Type (2018-2024) & (US$ Million)
Table 52. US & Canada Autologous Cell Therapy Products Revenue by Type (2024-2029) & (US$ Million)
Table 53. US & Canada Autologous Cell Therapy Products Sales by Application (2018-2024) & (K Units)
Table 54. US & Canada Autologous Cell Therapy Products Sales by Application (2024-2029) & (K Units)
Table 55. US & Canada Autologous Cell Therapy Products Revenue by Application (2018-2024) & (US$ Million)
Table 56. US & Canada Autologous Cell Therapy Products Revenue by Application (2024-2029) & (US$ Million)
Table 57. US & Canada Autologous Cell Therapy Products Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 58. US & Canada Autologous Cell Therapy Products Revenue by Country (2018-2024) & (US$ Million)
Table 59. US & Canada Autologous Cell Therapy Products Revenue by Country (2024-2029) & (US$ Million)
Table 60. US & Canada Autologous Cell Therapy Products Sales by Country (2018-2024) & (K Units)
Table 61. US & Canada Autologous Cell Therapy Products Sales by Country (2024-2029) & (K Units)
Table 62. Europe Autologous Cell Therapy Products Sales by Type (2018-2024) & (K Units)
Table 63. Europe Autologous Cell Therapy Products Sales by Type (2024-2029) & (K Units)
Table 64. Europe Autologous Cell Therapy Products Revenue by Type (2018-2024) & (US$ Million)
Table 65. Europe Autologous Cell Therapy Products Revenue by Type (2024-2029) & (US$ Million)
Table 66. Europe Autologous Cell Therapy Products Sales by Application (2018-2024) & (K Units)
Table 67. Europe Autologous Cell Therapy Products Sales by Application (2024-2029) & (K Units)
Table 68. Europe Autologous Cell Therapy Products Revenue by Application (2018-2024) & (US$ Million)
Table 69. Europe Autologous Cell Therapy Products Revenue by Application (2024-2029) & (US$ Million)
Table 70. Europe Autologous Cell Therapy Products Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 71. Europe Autologous Cell Therapy Products Revenue by Country (2018-2024) & (US$ Million)
Table 72. Europe Autologous Cell Therapy Products Revenue by Country (2024-2029) & (US$ Million)
Table 73. Europe Autologous Cell Therapy Products Sales by Country (2018-2024) & (K Units)
Table 74. Europe Autologous Cell Therapy Products Sales by Country (2024-2029) & (K Units)
Table 75. China Autologous Cell Therapy Products Sales by Type (2018-2024) & (K Units)
Table 76. China Autologous Cell Therapy Products Sales by Type (2024-2029) & (K Units)
Table 77. China Autologous Cell Therapy Products Revenue by Type (2018-2024) & (US$ Million)
Table 78. China Autologous Cell Therapy Products Revenue by Type (2024-2029) & (US$ Million)
Table 79. China Autologous Cell Therapy Products Sales by Application (2018-2024) & (K Units)
Table 80. China Autologous Cell Therapy Products Sales by Application (2024-2029) & (K Units)
Table 81. China Autologous Cell Therapy Products Revenue by Application (2018-2024) & (US$ Million)
Table 82. China Autologous Cell Therapy Products Revenue by Application (2024-2029) & (US$ Million)
Table 83. Asia Autologous Cell Therapy Products Sales by Type (2018-2024) & (K Units)
Table 84. Asia Autologous Cell Therapy Products Sales by Type (2024-2029) & (K Units)
Table 85. Asia Autologous Cell Therapy Products Revenue by Type (2018-2024) & (US$ Million)
Table 86. Asia Autologous Cell Therapy Products Revenue by Type (2024-2029) & (US$ Million)
Table 87. Asia Autologous Cell Therapy Products Sales by Application (2018-2024) & (K Units)
Table 88. Asia Autologous Cell Therapy Products Sales by Application (2024-2029) & (K Units)
Table 89. Asia Autologous Cell Therapy Products Revenue by Application (2018-2024) & (US$ Million)
Table 90. Asia Autologous Cell Therapy Products Revenue by Application (2024-2029) & (US$ Million)
Table 91. Asia Autologous Cell Therapy Products Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 92. Asia Autologous Cell Therapy Products Revenue by Region (2018-2024) & (US$ Million)
Table 93. Asia Autologous Cell Therapy Products Revenue by Region (2024-2029) & (US$ Million)
Table 94. Asia Autologous Cell Therapy Products Sales by Region (2018-2024) & (K Units)
Table 95. Asia Autologous Cell Therapy Products Sales by Region (2024-2029) & (K Units)
Table 96. Middle East, Africa and Latin America Autologous Cell Therapy Products Sales by Type (2018-2024) & (K Units)
Table 97. Middle East, Africa and Latin America Autologous Cell Therapy Products Sales by Type (2024-2029) & (K Units)
Table 98. Middle East, Africa and Latin America Autologous Cell Therapy Products Revenue by Type (2018-2024) & (US$ Million)
Table 99. Middle East, Africa and Latin America Autologous Cell Therapy Products Revenue by Type (2024-2029) & (US$ Million)
Table 100. Middle East, Africa and Latin America Autologous Cell Therapy Products Sales by Application (2018-2024) & (K Units)
Table 101. Middle East, Africa and Latin America Autologous Cell Therapy Products Sales by Application (2024-2029) & (K Units)
Table 102. Middle East, Africa and Latin America Autologous Cell Therapy Products Revenue by Application (2018-2024) & (US$ Million)
Table 103. Middle East, Africa and Latin America Autologous Cell Therapy Products Revenue by Application (2024-2029) & (US$ Million)
Table 104. Middle East, Africa and Latin America Autologous Cell Therapy Products Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 105. Middle East, Africa and Latin America Autologous Cell Therapy Products Revenue by Country (2018-2024) & (US$ Million)
Table 106. Middle East, Africa and Latin America Autologous Cell Therapy Products Revenue by Country (2024-2029) & (US$ Million)
Table 107. Middle East, Africa and Latin America Autologous Cell Therapy Products Sales by Country (2018-2024) & (K Units)
Table 108. Middle East, Africa and Latin America Autologous Cell Therapy Products Sales by Country (2024-2029) & (K Units)
Table 109. Novartis Company Information
Table 110. Novartis Description and Major Businesses
Table 111. Novartis Autologous Cell Therapy Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 112. Novartis Autologous Cell Therapy Products Product Model Numbers, Pictures, Descriptions and Specifications
Table 113. Novartis Recent Developments
Table 114. Gilead Sciences Company Information
Table 115. Gilead Sciences Description and Major Businesses
Table 116. Gilead Sciences Autologous Cell Therapy Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 117. Gilead Sciences Autologous Cell Therapy Products Product Model Numbers, Pictures, Descriptions and Specifications
Table 118. Gilead Sciences Recent Developments
Table 119. Bristol-Myers Squibb Company Information
Table 120. Bristol-Myers Squibb Description and Major Businesses
Table 121. Bristol-Myers Squibb Autologous Cell Therapy Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 122. Bristol-Myers Squibb Autologous Cell Therapy Products Product Model Numbers, Pictures, Descriptions and Specifications
Table 123. Bristol-Myers Squibb Recent Developments
Table 124. Johnson & Johnson Company Information
Table 125. Johnson & Johnson Description and Major Businesses
Table 126. Johnson & Johnson Autologous Cell Therapy Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 127. Johnson & Johnson Autologous Cell Therapy Products Product Model Numbers, Pictures, Descriptions and Specifications
Table 128. Johnson & Johnson Recent Developments
Table 129. Autolus Therapeutics Company Information
Table 130. Autolus Therapeutics Description and Major Businesses
Table 131. Autolus Therapeutics Autologous Cell Therapy Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 132. Autolus Therapeutics Autologous Cell Therapy Products Product Model Numbers, Pictures, Descriptions and Specifications
Table 133. Autolus Therapeutics Recent Developments
Table 134. FOSUNKite Company Information
Table 135. FOSUNKite Description and Major Businesses
Table 136. FOSUNKite Autologous Cell Therapy Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 137. FOSUNKite Autologous Cell Therapy Products Product Model Numbers, Pictures, Descriptions and Specifications
Table 138. FOSUNKite Recent Developments
Table 139. JW Therapeutics Company Information
Table 140. JW Therapeutics Description and Major Businesses
Table 141. JW Therapeutics Autologous Cell Therapy Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 142. JW Therapeutics Autologous Cell Therapy Products Product Model Numbers, Pictures, Descriptions and Specifications
Table 143. JW Therapeutics Recent Developments
Table 144. CARsgen Therapeutics Company Information
Table 145. CARsgen Therapeutics Description and Major Businesses
Table 146. CARsgen Therapeutics Autologous Cell Therapy Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 147. CARsgen Therapeutics Autologous Cell Therapy Products Product Model Numbers, Pictures, Descriptions and Specifications
Table 148. CARsgen Therapeutics Recent Developments
Table 149. Sorrento Therapeutics Company Information
Table 150. Sorrento Therapeutics Description and Major Businesses
Table 151. Sorrento Therapeutics Autologous Cell Therapy Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 152. Sorrento Therapeutics Autologous Cell Therapy Products Product Model Numbers, Pictures, Descriptions and Specifications
Table 153. Sorrento Therapeutics Recent Developments
Table 154. Mustang Bio Company Information
Table 155. Mustang Bio Description and Major Businesses
Table 156. Mustang Bio Autologous Cell Therapy Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 157. Mustang Bio Autologous Cell Therapy Products Product Model Numbers, Pictures, Descriptions and Specifications
Table 158. Mustang Bio Recent Developments
Table 159. Cellectis Company Information
Table 160. Cellectis Description and Major Businesses
Table 161. Cellectis Autologous Cell Therapy Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 162. Cellectis Autologous Cell Therapy Products Product Model Numbers, Pictures, Descriptions and Specifications
Table 163. Cellectis Recent Developments
Table 164. Allogene Therapeutics Company Information
Table 165. Allogene Therapeutics Description and Major Businesses
Table 166. Allogene Therapeutics Autologous Cell Therapy Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 167. Allogene Therapeutics Autologous Cell Therapy Products Product Model Numbers, Pictures, Descriptions and Specifications
Table 168. Allogene Therapeutics Recent Developments
Table 169. Celyad Oncology Company Information
Table 170. Celyad Oncology Description and Major Businesses
Table 171. Celyad Oncology Autologous Cell Therapy Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 172. Celyad Oncology Autologous Cell Therapy Products Product Model Numbers, Pictures, Descriptions and Specifications
Table 173. Celyad Oncology Recent Developments
Table 174. Bluebird Bio Company Information
Table 175. Bluebird Bio Description and Major Businesses
Table 176. Bluebird Bio Autologous Cell Therapy Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 177. Bluebird Bio Autologous Cell Therapy Products Product Model Numbers, Pictures, Descriptions and Specifications
Table 178. Bluebird Bio Recent Developments
Table 179. Lonza Company Information
Table 180. Lonza Description and Major Businesses
Table 181. Lonza Autologous Cell Therapy Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 182. Lonza Autologous Cell Therapy Products Product Model Numbers, Pictures, Descriptions and Specifications
Table 183. Lonza Recent Developments
Table 184. Key Raw Materials Lists
Table 185. Raw Materials Key Suppliers Lists
Table 186. Autologous Cell Therapy Products Distributors List
Table 187. Autologous Cell Therapy Products Customers List
Table 188. Autologous Cell Therapy Products Market Trends
Table 189. Autologous Cell Therapy Products Market Drivers
Table 190. Autologous Cell Therapy Products Market Challenges
Table 191. Autologous Cell Therapy Products Market Restraints
Table 192. Research Programs/Design for This Report
Table 193. Key Data Information from Secondary Sources
Table 194. Key Data Information from Primary Sources
List of Figures
Figure 1. Autologous Cell Therapy Products Product Picture
Figure 2. Global Autologous Cell Therapy Products Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Autologous Cell Therapy Products Market Share by Type in 2022 & 2029
Figure 4. Autologous Stem Cell Transplants Product Picture
Figure 5. Autologous T Cell Therapies Product Picture
Figure 6. Platelet-Rich Plasma (PRP) Therapy Product Picture
Figure 7. Others Product Picture
Figure 8. Global Autologous Cell Therapy Products Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 9. Global Autologous Cell Therapy Products Market Share by Application in 2022 & 2029
Figure 10. Cancer
Figure 11. Hemophilia
Figure 12. Others
Figure 13. Autologous Cell Therapy Products Report Years Considered
Figure 14. Global Autologous Cell Therapy Products Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 15. Global Autologous Cell Therapy Products Revenue 2018-2029 (US$ Million)
Figure 16. Global Autologous Cell Therapy Products Revenue Market Share by Region in Percentage: 2022 Versus 2029
Figure 17. Global Autologous Cell Therapy Products Revenue Market Share by Region (2018-2029)
Figure 18. Global Autologous Cell Therapy Products Sales 2018-2029 ((K Units)
Figure 19. Global Autologous Cell Therapy Products Sales Market Share by Region (2018-2029)
Figure 20. US & Canada Autologous Cell Therapy Products Sales YoY (2018-2029) & (K Units)
Figure 21. US & Canada Autologous Cell Therapy Products Revenue YoY (2018-2029) & (US$ Million)
Figure 22. Europe Autologous Cell Therapy Products Sales YoY (2018-2029) & (K Units)
Figure 23. Europe Autologous Cell Therapy Products Revenue YoY (2018-2029) & (US$ Million)
Figure 24. China Autologous Cell Therapy Products Sales YoY (2018-2029) & (K Units)
Figure 25. China Autologous Cell Therapy Products Revenue YoY (2018-2029) & (US$ Million)
Figure 26. Asia (excluding China) Autologous Cell Therapy Products Sales YoY (2018-2029) & (K Units)
Figure 27. Asia (excluding China) Autologous Cell Therapy Products Revenue YoY (2018-2029) & (US$ Million)
Figure 28. Middle East, Africa and Latin America Autologous Cell Therapy Products Sales YoY (2018-2029) & (K Units)
Figure 29. Middle East, Africa and Latin America Autologous Cell Therapy Products Revenue YoY (2018-2029) & (US$ Million)
Figure 30. The Autologous Cell Therapy Products Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 31. The Top 5 and 10 Largest Manufacturers of Autologous Cell Therapy Products in the World: Market Share by Autologous Cell Therapy Products Revenue in 2022
Figure 32. Global Autologous Cell Therapy Products Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 33. Global Autologous Cell Therapy Products Sales Market Share by Type (2018-2029)
Figure 34. Global Autologous Cell Therapy Products Revenue Market Share by Type (2018-2029)
Figure 35. Global Autologous Cell Therapy Products Sales Market Share by Application (2018-2029)
Figure 36. Global Autologous Cell Therapy Products Revenue Market Share by Application (2018-2029)
Figure 37. US & Canada Autologous Cell Therapy Products Sales Market Share by Type (2018-2029)
Figure 38. US & Canada Autologous Cell Therapy Products Revenue Market Share by Type (2018-2029)
Figure 39. US & Canada Autologous Cell Therapy Products Sales Market Share by Application (2018-2029)
Figure 40. US & Canada Autologous Cell Therapy Products Revenue Market Share by Application (2018-2029)
Figure 41. US & Canada Autologous Cell Therapy Products Revenue Share by Country (2018-2029)
Figure 42. US & Canada Autologous Cell Therapy Products Sales Share by Country (2018-2029)
Figure 43. U.S. Autologous Cell Therapy Products Revenue (2018-2029) & (US$ Million)
Figure 44. Canada Autologous Cell Therapy Products Revenue (2018-2029) & (US$ Million)
Figure 45. Europe Autologous Cell Therapy Products Sales Market Share by Type (2018-2029)
Figure 46. Europe Autologous Cell Therapy Products Revenue Market Share by Type (2018-2029)
Figure 47. Europe Autologous Cell Therapy Products Sales Market Share by Application (2018-2029)
Figure 48. Europe Autologous Cell Therapy Products Revenue Market Share by Application (2018-2029)
Figure 49. Europe Autologous Cell Therapy Products Revenue Share by Country (2018-2029)
Figure 50. Europe Autologous Cell Therapy Products Sales Share by Country (2018-2029)
Figure 51. Germany Autologous Cell Therapy Products Revenue (2018-2029) & (US$ Million)
Figure 52. France Autologous Cell Therapy Products Revenue (2018-2029) & (US$ Million)
Figure 53. U.K. Autologous Cell Therapy Products Revenue (2018-2029) & (US$ Million)
Figure 54. Italy Autologous Cell Therapy Products Revenue (2018-2029) & (US$ Million)
Figure 55. Russia Autologous Cell Therapy Products Revenue (2018-2029) & (US$ Million)
Figure 56. China Autologous Cell Therapy Products Sales Market Share by Type (2018-2029)
Figure 57. China Autologous Cell Therapy Products Revenue Market Share by Type (2018-2029)
Figure 58. China Autologous Cell Therapy Products Sales Market Share by Application (2018-2029)
Figure 59. China Autologous Cell Therapy Products Revenue Market Share by Application (2018-2029)
Figure 60. Asia Autologous Cell Therapy Products Sales Market Share by Type (2018-2029)
Figure 61. Asia Autologous Cell Therapy Products Revenue Market Share by Type (2018-2029)
Figure 62. Asia Autologous Cell Therapy Products Sales Market Share by Application (2018-2029)
Figure 63. Asia Autologous Cell Therapy Products Revenue Market Share by Application (2018-2029)
Figure 64. Asia Autologous Cell Therapy Products Revenue Share by Region (2018-2029)
Figure 65. Asia Autologous Cell Therapy Products Sales Share by Region (2018-2029)
Figure 66. Japan Autologous Cell Therapy Products Revenue (2018-2029) & (US$ Million)
Figure 67. South Korea Autologous Cell Therapy Products Revenue (2018-2029) & (US$ Million)
Figure 68. China Taiwan Autologous Cell Therapy Products Revenue (2018-2029) & (US$ Million)
Figure 69. Southeast Asia Autologous Cell Therapy Products Revenue (2018-2029) & (US$ Million)
Figure 70. India Autologous Cell Therapy Products Revenue (2018-2029) & (US$ Million)
Figure 71. Middle East, Africa and Latin America Autologous Cell Therapy Products Sales Market Share by Type (2018-2029)
Figure 72. Middle East, Africa and Latin America Autologous Cell Therapy Products Revenue Market Share by Type (2018-2029)
Figure 73. Middle East, Africa and Latin America Autologous Cell Therapy Products Sales Market Share by Application (2018-2029)
Figure 74. Middle East, Africa and Latin America Autologous Cell Therapy Products Revenue Market Share by Application (2018-2029)
Figure 75. Middle East, Africa and Latin America Autologous Cell Therapy Products Revenue Share by Country (2018-2029)
Figure 76. Middle East, Africa and Latin America Autologous Cell Therapy Products Sales Share by Country (2018-2029)
Figure 77. Brazil Autologous Cell Therapy Products Revenue (2018-2029) & (US$ Million)
Figure 78. Mexico Autologous Cell Therapy Products Revenue (2018-2029) & (US$ Million)
Figure 79. Turkey Autologous Cell Therapy Products Revenue (2018-2029) & (US$ Million)
Figure 80. Israel Autologous Cell Therapy Products Revenue (2018-2029) & (US$ Million)
Figure 81. GCC Countries Autologous Cell Therapy Products Revenue (2018-2029) & (US$ Million)
Figure 82. Autologous Cell Therapy Products Value Chain
Figure 83. Autologous Cell Therapy Products Production Process
Figure 84. Channels of Distribution
Figure 85. Distributors Profiles
Figure 86. Bottom-up and Top-down Approaches for This Report
Figure 87. Data Triangulation
Figure 88. Key Executives Interviewed